Prescription of lipid-lowering therapy, LDLc control, and risk of MACE in patients after ST-elevation myocardial infarction in Mexico

8 March 2024 (08:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Risk factors, prevention, and pharmacotherapy Secondary Prevention ACVC Premium Access ESC Acute CardioVascular Care 2024 Association for Acute CardioVascular Care (ACVC)

ESC 365 is supported by

ESC 365 is supported by